Harvard Atherosclerosis Reversibility Project (HARP)

首次发布于 1999 年 10 月 28 日

Running Successful Journal Club

计划入组 40 人 · 首次发布于 2012 年 6 月 18 日

Arthritis Health Journal Proof of Concept Study

计划入组 95 人 · 首次发布于 2013 年 9 月 13 日

ALR2 Inhibitors (Beijing Institute of Technology (BIT))

combination therapy (University of New Mexico/Science & Technology Corporation)

plasminogen activator/fibrinolysis stimulator (Harvard)

Harvard Apparatus Regenerative Technology, Inc.

United States

HARVARD SCHOOL OF PUBLIC HEALTH

United States

HARVARD SCHOOL OF DENTAL MEDICINE

United States

Study Reveals Surprising Link Between Patent Prosecution Length and Invalidity Risk

Harvard Apparatus Regenerative Technology and Capital Institute of Pediatrics Collaborate on Esophageal Atresia Treatment

Harvard Apparatus Regenerative Technology Partners with Capital Institute of Pediatrics for Esophageal Atresia Treatment